ReportsnReports.com: Drugs of Abuse Testing Markets

17-Jul-2011 | News-Press Release

This TriMark Publications report describes the specific segment of the in vitro diagnostics (IVD) market known as drugs of abuse testing. In the current medical diagnostics market, drugs of abuse testing offers promise for significant growth and innovation. Examined in this study are assays for alcohol, cannabinoids, cocaine, amphetamines, opiates and phencyclidine, as well as assays for addictive prescription drugs such as OxyContin.


Buy Now: Drugs of Abuse Testing Markets

Browse All: Pharmaceuticals Market Research

Moreover, special attention is paid to Substance Abuse and Mental Health Service Administration (SAMHSA) requirements, which aims to prevent substance abuse in the U.S. and so requires that certain corporations comply with anti-drug policies and testing. This review covers the leading market players, the competitive landscape, and the promising pipeline products in the drugs of abuse testing markets. Specifically, areas examined in this study include: available and developing technologies in the field, the U.S. and global market size for drugs of abuse tests, and the profiles of companies that are focusing on the drugs of abuse testing market. Detailed charts with sales forecasts and market share data for the U.S. and global drugs of abuse testing markets are included.

About Us:
ReportsnReports is an online library of over 75,000 market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004 EXT 106
E-mail: sales@reportsnreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

Show HTML Embed Snippet

This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.

Contact Info

From Name
From Email
From Company
Message
Login to Submit Email

Author Info

Tag Cloud

Categories

More Releases

Comments

Add a Comment

    \n\